
Systematic Coronary Risk Evaluation 2 (SCORE2) - MDCalc
The Systematic Coronary Risk Evaluation 2 (SCORE2) predicts 10-year CVD risk in patients without prior CVD or diabetes.
SCORE2 and SCORE2-OP - European Society of Cardiology
On HeartScore you can find an interactive tool based on the SCORE2 and SCORE2-OP algorithms. Access HeartScore. SCORE2 risk prediction algorithms: new models to estimate …
Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) - MDCalc
Predicts 10-year CVD risk in older patients. Use in patients ≥70 years. See Evidence for definition of risk regions. Please fill out required fields. In collaboration with the European Society of …
HeartScore
HeartScore is now updated with the SCORE2 and SCORE2-OP algorithms with recommendations for physicians and patients, from the 2021 ESC Guidelines on CVD …
ESC CVD Risk Calculation App - European Society of Cardiology
Assess individual cardiovascular risk for different patient populations. Developed by the European Association of Preventive Cardiology, the ESC CVD Risk Calculation App provides guidance …
HeartScore® - European Society of Cardiology
HeartScore is the ESC interactive tool to calculate the 10-year risk of fatal and non-fatal cardiovascular disease events, updated with SCORE 2, SCORE 2-OP and recommendations …
Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes) - MDCalc
SCORE2-Diabetes predicts 10-year CVD risk in patients with type 2 diabetes.
EuroScore Website - calculator
Important: EuroSCORE II is the current EuroSCORE calculator which should be used to calculate risk for current patients. If you need to calculate the older EuroSCORE I (additive or logistic), …
ESC CVD Risk Calculation - Apps on Google Play
Feb 6, 2025 · It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App. This …
MIRACLE2: Calculate risk of poor neurological outcome after …
Calculate risk of poor neurological outcome after out of hospital cardiac arrest. Researched and developed by King's College London with the support of Heart Research UK. Designed and …